Global Research PartnershipsCreate free account
Industry Collaboration Index

Industry Collaboration Index 2026 · University profile

London School of Hygiene & Tropical Medicine

United Kingdom · Europe · Silver

#305World rank of 1,038
62.1ICI scoreout of 100
#28National rank, of 62 in United Kingdom
#131Regional rank, of 388 in Europe
873.5Verified industry works, 2021 to 2025
336Company groups worked with (120 on two or more works)

London School of Hygiene & Tropical Medicine is ranked #305 of 1,038, with Silver standing. Its strongest pillar is durability (87): 40 of its company groups are sustained partners (five or more joint works in three or more of the five years). It is held back most by breadth (8): partners concentrated in a few research fields.

Research Collaboration Index 2026: #181 of 1,195, Gold standing · View the RCI profile →

Why this position

Four pillars, as percentiles

Co-creation30% of the score
76

How often it co-authors with companies, compared with what its own mix of research fields would predict; size makes no difference. 873.5 verified works against about 667 expected for its fields (1.31 times the expected rate).

Durability20% of the score
87

How much of its industry work sits in sustained partnerships with the same company group. 40 sustained partnerships: five or more joint works in three or more of the five years.

Scale30% of the score
68

The size of its industry network: company groups on two or more works, sustained partnerships, and its place in the worldwide network of universities and companies. 120 company groups on two or more joint works; 40 sustained partnerships.

Breadth20% of the score
8

How varied its partners are, judged by each company's main research field. Measured across the main research fields of all the company groups it worked with.

Each pillar is a percentile among the 1,038 ranked universities: a value of 80 means a higher value than about 80 in every 100 of them. The ICI score (62.1) is the weighted average of the four percentiles. Rank 305 of 1,038 overall; 28 of 62 in United Kingdom; 131 of 388 in Europe. Standing bands: Platinum for ranks 1 to 100, Gold 101 to 300, Silver 301 to 600. How the index is built →

In numbers

The evidence behind the position

4.6%of its 19,114 research works in 2021 to 2025 were co-authored with a verified company
1.31Industry co-authorship rate: 1.31 times what its mix of research fields would predict (873.5 verified works; about 667 expected)
40sustained partnerships: the same company group on five or more joint works in three or more of the five years

In United Kingdom

28 of 62 ranked universities in United Kingdom

  1. #26 University of Strathclyde world #265, score 64.7
  2. #27 University of Bath world #284, score 63.4
  3. #28 London School of Hygiene & Tropical Medicine world #305, score 62.1
  4. #29 Queen's University Belfast world #310, score 61.9
  5. #30 University of Dundee world #316, score 61.7

All ranked universities →   Europe: 131 of 388 →

Where it works with industry

Sector strengths

Verified industry works by sector, with its position in each sector ranking. A university is ranked in a sector once it has at least 20 verified works there; sectors with fewer than 50 eligible universities are provisional.

Strongest sector positions

#195 of 638Pharmaceuticals and Therapeutics164.5 verified works in the sector
Pharmaceuticals and Therapeutics
164.5#195 of 638
Climate, Environment and Sustainability
23.5#341 of 373
Medical Technology and Digital Health
15under 20 works
Agriculture and Food Technology
4under 20 works
Biotechnology and Advanced Therapies
3under 20 works
Chemicals, Process and Resources
3under 20 works
Artificial Intelligence
2under 20 works
Software, Cloud and Data
2under 20 works
Cybersecurity and Digital Trust
1under 20 works
Not in any of the 21 sectors
655.5counted in the overall index

218 of its 873.5 verified industry works fall within the 21 sectors. The rest have research topics that belong to no industry sector (basic science, for example) or are consortium papers with 100 or more authors, which the sector indices leave out; all of them count fully in the overall index.

Who it works with

Company partners, 2021 to 2025

London School of Hygiene & Tropical Medicine co-authored verified work with 336 company groups, consortium papers aside: 120 of them on two or more works, and 40 as sustained partners.

The largest 12 of its 336 company groups, by joint works

Company groupBased inCompany's main research fieldJoint worksYears with a joint work
Boehringer IngelheimGermanyMedicine745 of 5
Johnson & JohnsonUnited StatesMedicine54.55 of 5
GlaxoSmithKlineUnited KingdomMedicine53.55 of 5
AstraZenecaUnited KingdomMedicine485 of 5
PfizerUnited StatesMedicine29.55 of 5
SanofiFranceMedicine264 of 5
NovartisSwitzerlandMedicine20.55 of 5
IQVIAUnited StatesMedicine205 of 5
MicrosoftUnited StatesComputer Science19.55 of 5
BayerGermanyMedicine195 of 5
RocheSwitzerlandMedicine17.55 of 5
Merck & Co. (MSD)United StatesMedicine175 of 5

A company group brings together a company's subsidiaries and research labs under one name. A work counts half when its only company author also holds a post at this university. Consortium papers with 100 or more authors are left out of this table.

Examples of its work with industry

Most-cited verified joint works

Its most-cited verified works with 30 or fewer authors, leaving out guidelines and consensus statements. Citation counts are those of the open scholarly record at harvest. Each title links to the work.

Over time

Verified industry works by year

171.52021
1962022
177.52023
176.52024
1522025

2025 is not yet complete: papers published late in the year are still being added to the open record, and coverage may not be equally complete for every university, so compare years with care. A work counts half when its only company author also holds a post at the university, so some totals end in .5.

Clinical trials (reported, not scored)

3 industry-partnered clinical trials

Trials starting 2021 to 2025 in ClinicalTrials.gov in which a company and this university are the sponsor and a collaborator. Names are matched exactly, so a trial registered only under an affiliated hospital's own name is not counted here, and the count can be well below the university's real trial activity. Trials do not enter the score.

Examples:

  • NCT06923592 Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar with Institut Pasteur, 2025
  • NCT05546242 Improving HIV-1 Control in Africa with Long Acting Antiretrovirals with Janssen Pharmaceuticals, 2022
  • NCT05284097 Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study with Janssen Vaccines & Prevention B.V., 2022

Funded partnerships (reported, not scored)

Publicly funded research projects with companies

European Union: 19 Horizon projects with company partners

Horizon 2020 and Horizon Europe projects starting 2021-2025 in which this university and at least one company take part (28 distinct companies). Most frequent: Bioeclosion SL, Inserm Transfert SA, Wits Health Consortium (pty) Ltd, Aquatim SA, CZ Vaccines S.a., Delft Imaging Ghana Ltd.

  • UNITE4TB ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS 2021, 4 companies
  • MVC-2G Optimising a Deployable High Efficacy Multi-Stage Vaccine for Plasmodium falciparum Malaria: 2nd Generation Malaria Vaccine Consortium 2025, 1 company
  • HIGH Horizons Heat Indicators for Global Health (HIGH Horizons): monitoring, Early Warning Systems and health facility interventions for pregnant and... 2022, 1 company

United Kingdom: 10 UKRI projects with named company partners

Projects funded through UK Research and Innovation (research councils and Innovate UK, including Knowledge Transfer Partnerships) starting 2021-2025 in which this university takes part and at least one company is a named partner (12 distinct companies, including collaborations reported after the award). Most frequent: Roche Diagnostics Ltd, Astrazeneca, Biogents AG, Gilead Sciences Limited, GlaxoSmithKline (Global), Microplate Dx Limited.

Shown for context from the public grant registries; they do not enter the score in Edition 1. Comparable open registries of company partners exist for the European Union and the United Kingdom but not yet for most other research systems, and in some countries national research organisations take part on behalf of university laboratories, so these counts are not comparable between countries.

Funded and co-publishing. Of the funded company partners that match an ICI company group, 5 also appear in this university's verified co-authorship record (Roche, GlaxoSmithKline, AstraZeneca, Gilead Sciences, Novavax) and 5 are funded partners not yet visible in it. About 29% of funded company names could be matched to a company group; the rest are counted, not guessed. Sources: UKRI Gateway to Research harvested 4 Oct 2026; CORDIS bulk files of 2026-10-12 (latest record update 2026-06-10). Funded partnerships cover UK (UKRI Gateway to Research) and EU (Horizon 2020 and Horizon Europe, CORDIS) projects starting 2021 to 2025 only. They are reported, never scored, and a funder record outside these two sources is not visible here.

Evidence checked

1,377 verified company links

Each counted link (one work, this university and one company) was confirmed against the affiliation text its author wrote; 1,199 of 2,576 candidate links were set aside.

Why links were set aside
  • 611 company name not written in the author's affiliation
  • 181 ordinary-word name without a company suffix
  • 77 part of a university or public institute's own unit
  • 61 a place or common word that failed its stricter rule
  • 37 excluded after hand audit: A university-owned company
  • 36 excluded after hand audit: A university research laboratory (InnoHK), not a company
  • 196 for other reasons: smaller hand-audit findings, and links the current open record no longer supports

If a partner is missing or should not be here, send the evidence; corrections are free and reviewed against the public record.

For your communications

Badges you can use

Silver standing badge

Use the badge with a link to this page.

GRP Partnership Intelligence Platform

Where London School of Hygiene & Tropical Medicine's collaboration could go next

This profile is free and public, and it stays that way. Beyond it, the GRP Partnership Intelligence Platform, a partner service arranged with each university, sets your record in both GRP indices beside the peers you choose: the universities and companies your peers work with that you do not, live funding calls matched to your strengths, the EU projects your peers have won, and a brief ready for your executive. It opens to partner universities on Monday 19 October 2026: enquire, and the GRP team will confirm availability and pricing for your university.

Request first access →  See what is inside →

The platform cannot move any university's position, band or score.

The other GRP index

Research Collaboration Index

In the Research Collaboration Index 2026, London School of Hygiene & Tropical Medicine ranks #181 of 1,195, with Gold standing. It measures the whole research network, not only industry.

View the RCI profile →

Something wrong? Every figure comes from the public record and can be checked. If a partner is missing or should not be there, tell us and we will review it with the evidence. The 2027 edition will be calculated with the same published methodology. The window for universities to submit data for it is open now: submit data for the 2027 edition. The index is free, public and independent. No commercial relationship with any university or company changes any position, and no one can pay to be included, excluded or moved.